FDA Alert: Propafenone HCl Tablets (150 mg, 225 mg, 300 mg), Isosorbide Mononitrate Extended Release Tablets (30 mg and 60 mg), Alerts drugs.
Audience: Pharmacists, Other healthcare professionals, patients [Posted 11/10/2008] Ethex Corp and FDA notified healthcare professionals of a optional return of five generic Products (Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release Tablets, Morphine Sulfate Extended Release Tablets, Morphine Sulfate Immediate Release Tablets, and Dextroamphetamine Sulfate Tablets). The Products were recalled because they may control oversized tablets. Oversized tablets may repress more than the intended levels of the functioning medication element that could sequel in patients receiving as much as twice the expected dosage of these drugs, which could cause urgent or life-threatening consequences. Overdoses can comprehend arrhythmias and murmurous Blood constraint with Propafenone HCl; fainting and broken-hearted Blood arm-twisting with Isosorbide Mononitrate; respiratory hollow and stubby Blood tension with Morphine Sulfate; and speedy crux take to task and exhilarated Blood intimidate with Dextroamphetamine Sulfate.
Patients who know any adverse reactions to these drugs should telephone their healthcare efficient immediately. See the manufacturer's think back to information for determined lot numbers of the Products insincere by this recall. [November 07, 2008 - - Ethex Corp].
With respect to link: click
Related posts
Tags: blood, healthcare, morphine, patients, release, sulfate, tablets